Figure 3From: Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapyReceiver operating characteristic curve for ΔSCC-Ag in predicting the probability of a recurrence in patients with elevated pre-treatment tumor markers.Back to article page